Please Wait.....
Report
Immunoglobulins: Global Market Outlook
Market Research Report I 2023-03-30 I 64 Pages I BCC Research
Description
Report Scope:
The scope of this study encompasses the current and forecast markets for normal and hyper immunoglobulins. The report segments markets based on product type and route of administration. The report surveys the competitive landscape, market dynamics and current and developing technologies. The report also analyzes the impact of COVID-19 on the market.
In terms of geographical regions, the report analyzes the market across North America, Europe, Asia-Pacific and the rest of the world (RoW). Key regions such as the U.S., Canada, Europe (U.K., Italy, France and Germany), Asia-Pacific (China, India and Japan) are highlighted in the discussion.
The report also analyzes key companies and their recent developments, such as product launches, business expansions and collaborations.
Report Includes:
- A brief general outlook of the global market for immunoglobulins
- Analyses of the global market trends, with historic market revenue data (sales figures) for 2021, estimates for 2022, and projections of compound annual growth rates (CAGRs) through 2027
- Estimation of the actual market size and revenue forecast for the global immunoglobulins market in USD million terms, and corresponding market share analysis by product type, route of administration, and region
- In-depth information (facts and figures) concerning the major factors influencing the progress of this market (benefits, and industry-specific challenges) with respect to specific growth trends, upcoming technologies, current and future prospects in therapeutic treatments, and contributions to the overall market
- Identification of major stakeholders and analysis of the company competitive landscape based on their recent developments, financial performance, segmental revenues, and operational integration
- Company profiles of the market leading players
Executive Summary
Summary:
The global immunoglobulins (IG) market was estimated to be $REDACTED billion in 2021. The immunoglobulins market is projected to grow at a compound annual growth rate (CAGR) of REDACTED% and is expected to reach $REDACTED billion by the end of 2027. Increasing demand for immunoglobulins in various treatments and an increase in blood donations are the key factors driving the growth of the current immunoglobulins market. However, increasing research on alternative therapies and high manufacturing and treatment costs associated with immunoglobulin products could hinder market growth. Apart from drivers and restraints, growing investments in plasma fractionation capacities and increasing research on new formulations and indications should create huge opportunities for vendors in the market.
In this report, the global immunoglobulins market has been segmented based on type, route of administration and geographical region. Based on type, the immunoglobulins market has been categorized into normal and hyperimmune globulins. Normal immunoglobulins currently dominate the market and were valued at $REDACTED billion in 2021. The normal immunoglobulins market is expected to grow at a CAGR of REDACTED% and reach $REDACTED billion by the end of 2027.
Based on the route of administration, the immunoglobulins market has been segmented into intravenous (IV), subcutaneous (SC) and others. Among all route segments, the SC segment is expected to grow at the highest CAGR, REDACTED%, during the forecast period.
The immunoglobulins market has been segmented into the following geographical regions: North America; Europe; Asia-Pacific; and Rest of the World (RoW). The North American region currently dominates the global immunoglobulins market. In 2021, this region's total revenue reached $REDACTED billion, accounting for about REDACTED% of the global market. Key growth factors in this region include the presence of large fractionation facilities and the increasing demand for immunoglobulins in treating various immunodeficiency disorders. The Asia-Pacific immunoglobulins market was valued at $REDACTED billion in 2021. The Asia-Pacific immunoglobulins market is projected to grow at a CAGR of REDACTED% and reach $REDACTED billion by the end of 2027. The key growth driver of this region's market is the growing domestic plasma fractionation companies in countries such as South Korea and India.
Takeda Pharmaceutical Company Limited., CSL Ltd., Grifols International SA and Kedrion SpA are major players in the immunoglobulins market.
Table of Contents
Chapter 1 Introduction
1.1 Market Snapshot
Chapter 2 Executive Summary
Chapter 3 Market Overview
3.1 Immunoglobulin G (IgG)
3.2 Immunoglobulin M (IgM)
3.3 Immunoglobulin A (IgA)
3.4 Immunoglobulin E (IgE)
3.5 Immunoglobulin D (IgD)
3.6 Immunoglobulins Mechanism of Action
3.7 Clinical Use of Immunoglobulins
3.7.1 Replacement Therapy with Immunoglobulins
3.7.2 Immunoglobulin Blood Tests
3.8 Market Dynamics
3.8.1 Market Drivers
3.8.2 Market Restraints
Chapter 4 Emerging Technologies/ Opportunities
4.1 Growing Investments in Plasma Fractionation Capacities
4.2 Increasing Research on New Formulations and Indications
4.3 Growing Opportunities in Emerging Nations
4.4 Adoption of Digital Initiatives
Chapter 5 Market Breakdown by Type, Route of Administration
5.1 Immunoglobulins Market, by Type
5.1.1 Normal Immune Globulins
5.1.2 Hyperimmune Globulins
5.1.3 Market Size and Forecast
5.2 Immunoglobulins Market, by Route of Administration
5.2.1 Intravenous (IV) Administration
5.2.2 Subcutaneous (SC) Administration
5.2.3 Others
5.2.4 Market Size and Forecast
5.3 Normal Immunoglobulins Market, by Application
5.3.1 Primary Immune Deficiency (PID)
5.3.2 Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
5.3.3 Secondary Immune Deficiency (SID)
5.3.4 Multifocal Motor Neuropathy (MMN)
5.3.5 Other Neurological Disorders
5.3.6 Other Applications
5.3.7 Market Size and Forecast
Chapter 6 Market Breakdown by Region
6.1 Global Immunoglobulins Market Size, by Region
6.2 North America
6.3 Europe
6.4 Asia-Pacific
6.5 Rest of the World
Chapter 7 Competitive Landscape
7.1 Recent Key Developments
7.2 Product Launches
7.3 Mergers and Acquisitions
7.4 Business Expansions
7.5 Agreements and Collaborations
7.6 Clinical Trials Landscape
Chapter 8 COVID-19 Impact: Immunoglobulins Market
8.1 COVID-19 Impact on the Immunoglobulins Market
8.1.1 Convalescent Plasma (CP) Therapy and Hyperimmune Globulins for COVID-19 Treatment
Chapter 9 Company Profiles
ADMA BIOLOGICS INC.
BAXTER INTERNATIONAL
BIO PRODUCTS LABORATORY LTD.
CHINA BIOLOGIC PRODUCTS INC.
CSL LTD.
GRIFOLS INTERNATIONAL S.A.
INNOVATIVE RESEARCH
INTAS PHARMACEUTICALS LTD.
KEDRION SPA
LFB S.A.
OCTAPHARMA AG
SANQUIN
TAKEDA PHARMACEUTICAL COMPANY LIMITED.
Chapter 10 Project Scope and Methodology
10.1 Scope of Report
10.2 Methodology
10.3 Analyst's Credentials
10.4 BCC Custom Research
10.5 Related BCC Research Reports
List of Tables
Summary Table : Global Market for Immunoglobulins, by Region, Through 2027
Table 1 : Immunoglobulin Blood Tests to Diagnose Health Conditions
Table 2 : Global Market for Immunoglobulins, by Type, Through 2027
Table 3 : Comparison of Intravenous and Subcutaneous Immunoglobulins
Table 4 : Global Market for Immunoglobulins, by Route of Administration, Through 2027
Table 5 : Global Market for Normal Immunoglobulins, by Application, Through 2027
Table 6 : Global Market for Immunoglobulins, by Region, Through 2027
Table 7 : North American Market for Immunoglobulins, by Type, Through 2027
Table 8 : North American Market for Immunoglobulins, by Route of Administration, Through 2027
Table 9 : North American Market for Immunoglobulins, by Country, Through 2027
Table 10 : European Market for Immunoglobulins, by Type, Through 2027
Table 11 : European Market for Immunoglobulins, by Route of Administration, Through 2027
Table 12 : European Market for Immunoglobulins, by Country, Through 2027
Table 13 : Asia-Pacific Market for Immunoglobulins, by Type, Through 2027
Table 14 : Asia-Pacific Market for Immunoglobulins, by Route of Administration, Through 2027
Table 15 : Asia-Pacific Market for Immunoglobulins, by Country, Through 2027
Table 16 : RoW Market for Immunoglobulins, by Type, Through 2027
Table 17 : RoW Market for Immunoglobulins, by Route of Administration, Through 2027
Table 18 : Product Launches, by Key Competitors, 2020-2022
Table 19 : Mergers and Acquisitions of Key Competitors, 2020-2022
Table 20 : Business Expansion Activities, by Key Competitors, 2020-2022
Table 21 : Agreements and Collaborations Activities, by Key Competitors, 2020-2022
Table 22 : Clinical Trial Activities of Key Competitors on Immunoglobulin Products
Table 23 : ADMA Biologics Inc.: Product Portfolio
Table 24 : ADMA Biologics Inc.: Developments and Strategies, 2022
Table 25 : Bio Products Laboratory Ltd.: Product Portfolio
Table 26 : Bio Products Laboratory Ltd.: Developments and Strategies, 2022
Table 27 : China Biologic Products Inc.: Product Portfolio
Table 28 : China Biologic Products Inc.: Developments and Strategies, 2022
Table 29 : CSL Ltd.: Product Portfolio
Table 30 : CSL Ltd.: Developments and Strategies, 2022
Table 31 : Grifols International S.A.: Product Portfolio
Table 32 : Grifols International S.A.: Developments and Strategies, 2022
Table 33 : Kedrion SpA: Product Portfolio
Table 34 : Kedrion SpA: Developments and Strategies, 2022
Table 35 : LFB S.A.: Developments and Strategies, 2022
Table 36 : Octapharma AG: Product Portfolio
Table 37 : Octapharma AG: Developments and Strategies, 2022
Table 38 : Takeda Pharmaceutical Company Limited: Product Portfolio
Table 39 : Takeda Pharmaceutical Company Limited: Developments and Strategies, 2022
List of Figures
Summary Figure : Global Market Shares of Immunoglobulins, by Region, 2021
Figure 1 : Global Market Shares of Immunoglobulins, by Type, 2021
Figure 2 : Global Market Shares of Immunoglobulins, by Route of Administration, 2021
Figure 3 : Global Market Shares of Normal Immunoglobulins, by Application, 2021
Figure 4 : Global Immunoglobulins Market, by Region
Figure 5 : Global Market Shares of Immunoglobulins, by Region, 2021
Figure 6 : Global Market Shares of Immunoglobulins, by Region, 2027
Figure 7 : ADMA Biologics Inc.: Financials, 2020 and 2021
Figure 8 : ADMA Biologics Inc.: Revenue Share, by Segment, 2021
Figure 9 : ADMA Biologics Inc.: Revenue Share, by Region, 2021
Figure 10 : CSL Ltd.: Annual Revenue, 2019-2021
Figure 11 : CSL Ltd.: Revenue Share, by Region/Country, 2021
Figure 12 : Grifols International S.A.: Financials, 2019-2021
Figure 13 : Grifols International S.A.: Revenue Share, by Business Segment, 2021
Figure 14 : Grifols International S.A.: Revenue Share, by Region/Country, 2021
Figure 15 : Kedrion SpA: Financials, 2019-2021
Figure 16 : Kedrion SpA: Revenue Share, by Segment, 2021
Figure 17 : Kedrion SpA: Revenue Share, by Region, 2021
Figure 18 : Octapharma AG: Financials, 2019-2021
Figure 19 : Takeda Pharmaceutical Company Limited: Financials, 2020 and 2021
Figure 20 : Takeda Pharmaceutical Company Limited: Revenue Share, by Region, 2021
Figure 21 : Takeda Pharmaceutical Company Limited: Revenue Share, by Business Segment, 2021
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security